Armistice Capital »

Blue Owl Capital shares owned by Armistice Capital

Quarter-by-quarter ownership of Blue Owl Capital (OWL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Blue Owl Capital

Tip: Access up to 7 years of quarterly data

All positions including Blue Owl Capital held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blue Owl Capital by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $438k 48k 9.13

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Blue Owl Capital

FMR
Vanguard Group
Capital Research Global Investors
Capital World Investors
Vanguard Portfolio Management
ICONIQ Capital
BlackRock
Vanguard Capital Management
Susquehanna International
Bank of America Corporation
Lind Value II ApS
Morgan Stanley
Geode Capital Management
State Street Corporation
Goldman Sachs Group

View all funds holding Blue Owl Capital